Engineering and Development

Management and Executive

Legal and Compliance

Marketing

Customer Service and Support

Human Resources

Accounting and Finance

Sales

Product Management

Creatives and Design

President and Chief Executive Officer

Senior Vice President, Franchise Head Epilepsy and Movement Disorders

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

Jazz Pharmaceuticals price target raised by $5 at BofA, here's why

Jazz Pharmaceuticals Director Sells 5,500 Shares

FDA Approves Jazz Pharmaceuticals plc's Zepzelca (lurbinectedin) and Atezolizumab Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Executive Director, Head of Neuro-Oncology

Jazz Pharmaceuticals is a global biopharma company dedicated to developing life-changing medicines for serious diseases. The Head of Neuro-Oncology will lead the strategy and execution of Jazz’s US Neuro-Oncology franchise, focusing on commercial success and collaboration across functions to improve patient outcomes in neuro-oncology.

Senior Vice President, Business Unit Head, Sleep

Executive Director, IS Business partner, Jazz Pharma

Vice President, Neuropsychiatry

Executive Medical Director

Executive Director, Head of Alliance Management

Sign up with Google

Sign in with Google